Biotech firms developing ‘regenerative’ medicine to fight rare diseases merge in RTP
December 13, 2022, 5:34 pm
Stakeholders hope the merger will create a “complete company,” equipped to create regenerative medicines from development to manufacturing.
keywords
Research Triangle Park ~ Rare disease ~ The Charlotte Observer
